Temsirolimus, a novel mTOR inhibitor: its clinical development for renal cell carcinoma and other tumors
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Saunders
2009
|
| Schriftenreihe: | Seminars in oncology
Supplement ; 36,3 |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 58 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV035950086 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 100113s2009 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)635352585 | ||
| 035 | |a (DE-599)HBZHT016189576 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-355 | ||
| 245 | 1 | 0 | |a Temsirolimus, a novel mTOR inhibitor |b its clinical development for renal cell carcinoma and other tumors |c [Janet E. Dancey guest ed.] |
| 264 | 1 | |a New York, NY |b Saunders |c 2009 | |
| 300 | |a 58 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Seminars in oncology : Supplement |v 36,3 | |
| 700 | 1 | |a Dancey, Janet E. |4 edt | |
| 830 | 0 | |a Seminars in oncology |v Supplement ; 36,3 |w (DE-604)BV021331028 |9 36,3 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018807167&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-018807167 | ||
Datensatz im Suchindex
| _version_ | 1804140942599389184 |
|---|---|
| adam_text | Titel: Temsirolimus, a novel mTOR inhibitor
Autor: Dancey, Janet E.
Jahr: 2009
Seminars in
^ ^ % Vol 36, No 6, Suppl 3
?¦^eminars in i
Oncology,
December 2009
Temsirolimus, a Novel mTOR Inhibitor: Its Clinical Development
for Renal Cell Carcinoma and Other Tumors
Janet E. Dancey, MD, Guest Editor
TABLE OF CONTENTS
SI Clinical Development of Temsirolimus, a Novel mTOR Inhibitor, for
Treatment of Advanced Malignancies
Janet E. Dancey
S3 Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a
Signaling Pathway Important for Normal and Cancer Cell Growth
James J. Gibbons, Robert T. Abraham, and Ker Yu
SI8 Intravenous Temsirolimus in Cancer Patients: Clinical Pharmacology
and Dosing Considerations
Joseph P. Boni, Bruce Hug, Cathie Leister, and Daryl Sonnichsen
S26 Clinical Trial Experience With Temsirolimus in Patients With Advanced
Renal Cell Carcinoma
Gary R. Hudes, Anna Berkenblit, Jay Feingold, Michael B. Atkins,
Brian I. Rini, and Janice Dutcher
S37 Temsirolimus in Mantle Cell Lymphoma and Other Non-Hodgkin
Lymphoma Subtypes
Georg Hess, Sonali M. Smith, Anna Berkenblit, and Bertrand Coiffier
S46 Evaluating Temsirolimus Activity in Multiple Tumors: A Review of
Clinical Trials
Janet E. Dancey, Rafael Curiel, and Joseph Purvis
|
| any_adam_object | 1 |
| author2 | Dancey, Janet E. |
| author2_role | edt |
| author2_variant | j e d je jed |
| author_facet | Dancey, Janet E. |
| building | Verbundindex |
| bvnumber | BV035950086 |
| ctrlnum | (OCoLC)635352585 (DE-599)HBZHT016189576 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01126nam a2200277 cb4500</leader><controlfield tag="001">BV035950086</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">100113s2009 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)635352585</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHT016189576</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Temsirolimus, a novel mTOR inhibitor</subfield><subfield code="b">its clinical development for renal cell carcinoma and other tumors</subfield><subfield code="c">[Janet E. Dancey guest ed.]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Saunders</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">58 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Seminars in oncology : Supplement</subfield><subfield code="v">36,3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dancey, Janet E.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Seminars in oncology</subfield><subfield code="v">Supplement ; 36,3</subfield><subfield code="w">(DE-604)BV021331028</subfield><subfield code="9">36,3</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018807167&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018807167</subfield></datafield></record></collection> |
| id | DE-604.BV035950086 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T22:08:00Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018807167 |
| oclc_num | 635352585 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| physical | 58 S. Ill., graph. Darst. |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Saunders |
| record_format | marc |
| series | Seminars in oncology |
| series2 | Seminars in oncology : Supplement |
| spelling | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors [Janet E. Dancey guest ed.] New York, NY Saunders 2009 58 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Seminars in oncology : Supplement 36,3 Dancey, Janet E. edt Seminars in oncology Supplement ; 36,3 (DE-604)BV021331028 36,3 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018807167&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors Seminars in oncology |
| title | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors |
| title_auth | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors |
| title_exact_search | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors |
| title_full | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors [Janet E. Dancey guest ed.] |
| title_fullStr | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors [Janet E. Dancey guest ed.] |
| title_full_unstemmed | Temsirolimus, a novel mTOR inhibitor its clinical development for renal cell carcinoma and other tumors [Janet E. Dancey guest ed.] |
| title_short | Temsirolimus, a novel mTOR inhibitor |
| title_sort | temsirolimus a novel mtor inhibitor its clinical development for renal cell carcinoma and other tumors |
| title_sub | its clinical development for renal cell carcinoma and other tumors |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018807167&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV021331028 |
| work_keys_str_mv | AT danceyjanete temsirolimusanovelmtorinhibitoritsclinicaldevelopmentforrenalcellcarcinomaandothertumors |